Could a gentle brain zap help Parkinson's patients swallow safely?
NCT ID NCT07153692
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a mild electrical brain stimulation technique called tDCS can improve swallowing difficulties in people with Parkinson's disease. 58 participants will receive either real or sham tDCS alongside standard swallowing therapy. Researchers will measure changes in swallowing function and brain activity using video X-rays and brain scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcranial direct current stimulation (tDCS) device
- What this could lead to
- If it works, this could offer a non-drug way to improve swallowing safety and quality of life for people with Parkinson's disease.
- What could go wrong
- This is a small, early-stage trial with only 58 people. The improvement may be modest, and the effects might not last long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPHAGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which is safer for frail seniors: sedation or no sedation during feeding tube placement?
- Could a brain disease change behavior years before diagnosis?
- High-Resolution brain scans aim to unmask Tau's role in Parkinson's
- Breathing exercises may retrain swallowing in ICU survivors — a trial puts it to the test
- Zapping the brain to restore swallowing after stroke
- Can an experimental pill slow a rare brain disease? a trial puts ATH434 to the test.